Ricoh USA, Inc. and Kallisio today announced a strategic partnership to manufacture and distribute Stentra™, a 510(k)-cleared ...

GT Medical Technologies has obtained a $35 million venture loan facility to fund expansion of its technology to treat ...

GT Medical Technologies, maker of the GammaTile bioresorbable collagen tile, announced that it secured a $35 million venture ...

Alpha DaRT more precise compared to traditional radiation therapy ... received FDA Breakthrough Device Designation in June ...

Radiation is part of treatment for about half of cancer patients. A breakthrough could change the future of the treatment.

Highlights include new safety and efficacy data of Barrigel™rectal spacer, the first and only sculptable rectal spacer1-3• Teleflex to host ...

Secondary efficacy objectives of the Alpha DaRT cancer therapy study will focus on progression-free survival, overall ...

In the treatment of cancer patients, irradiation can be adapted anew each day to the position of the tumor and conditions in ...

Radiation is part of treatment ... called SCINTIX, from biotech company RefleXion. The FDA granted SCINTIX a Breakthrough Device designation in 2021, and in 2023 granted clearance to SCINTIX ...